Evidence map›Paper›PMID 35277106›Full record

ArticleDrug delivery2022

Silk fibroin hydrogel containing

Duy Toan Pham, Nguyen Thi Phuong Thao, Bui Thi Phuong Thuy, Van De Tran, Thanh Q C Nguyen, Ngoc Nha Thao Nguyen

Abstract read
In one paragraph

Article in Drug delivery, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Nanoparticle Delivery Systems in Rheumatoid Arthritis: More Than Vehicles.Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition · 2026
    Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Controlled-ReleaseClinical, cosmetic and investigational dermatology · 2023
    Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Hydrogels for the treatment of rheumatoid arthritis.Frontiers in bioengineering and biotechnology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Duy Toan PhamDepartment of Chemistry, College of Natural Sciences, Can Tho University, Can Tho, Vietnam.ORCID 0000-0002-8693-3367
Nguyen Thi Phuong ThaoDong Nai Technology University, Bien Hoa, Dong Nai, Vietnam.
Bui Thi Phuong ThuyFaculty of Basic Sciences, Van Lang University, Ho Chi Minh City, Vietnam.
Van De TranFaculty of Pharmacy, Can Tho University of Medicine and Pharmacy, Can Tho, Vietnam.
Thanh Q C NguyenDepartment of Chemistry, College of Natural Sciences, Can Tho University, Can Tho, Vietnam.
Ngoc Nha Thao NguyenFaculty of Pharmacy, Can Tho University of Medicine and Pharmacy, Can Tho, Vietnam.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeRheumatoid arthritis, a chronic and progressive inflammation condition in the joints, has significantly reduced the patient quality of life and life expectancy. Crucially, there is no complete therapy for this disease, and the current treatments possess numerous side effects. Thus, novel therapeutic approach is necessary. To that end, this study developed novel silk fibroin in-situ hydrogel containing

methodsThe hydrogels were manufactured using simple method of spontaneous gelation at different temperature. The gel properties of morphology, gelation time, viscosity, gel strength, stability, drug loading capacity, drug release rate, and in-vitro anti-inflammatory activity were investigated with appropriate methods.

resultsThe optimal formulation had highly porous structure, with a gelation time of 0.5 h at room temperature and bodily temperature of 37 °C, a viscosity of 2530 ± 50 cP, a gel strength of 1880.14 ± 35.10 g, and a physical stability of >6 months. Moreover, the hydrogel contained the

conclusionConclusively, the systems possessed potential properties to be further investigated to become a prospective rheumatoid arthritis treatment.

Indexed as

Arthritis, RheumatoidFibroinsHydrogelsSesbaniaDrug CarriersHumansPlant ExtractsProspective StudiesQuality of LifeDrug CarriersFibroinsHydrogelsPlant Extractsanti-inflammationHydrogelrheumatoid arthritisSesbania sesbanSilk fibroin

Identifiers

PMID35277106
PMCPMC8920400

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.